Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
COVID-19
100%
Solid Organ Transplantation
100%
Anti-SARS-CoV-2 Monoclonal Antibodies
100%
Solid Organ Transplant Recipients
85%
High Risk
28%
Pre-exposure Prophylaxis (PrEP)
28%
Treatment Options
14%
Early Treatment
14%
Hospitalization Risk
14%
Intensive Care
14%
Treatment Monitoring
14%
Early Prevention
14%
Immune Suppression
14%
Tolerability
14%
Epidemiological Risk
14%
Immunological Response
14%
Passive Immunity
14%
Diverse Populations
14%
Response to Vaccination
14%
Oral Treatment
14%
Viral Variants
14%
Close Monitoring
14%
Graft Injury
14%
Severe Adverse Events
14%
Effective Communication
14%
Multidisciplinary Team Approach
14%
Provider Awareness
14%
Underlying Medical Conditions
14%
Active Immunity
14%
Patient Awareness
14%
Timely Administration
14%
Anti-spike Monoclonal Antibodies
14%
Anti-SARS-CoV-2 Antibodies
14%
Medicine and Dentistry
Monoclonal Antibody
100%
COVID-19
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Solid Organ Transplantation
100%
Adverse Event
14%
Intensive Care
14%
Awareness
14%
Immunosuppressive Treatment
14%
Active Immunization
14%
Passive Immunization
14%
Post-Exposure Prophylaxis
14%
Pre-Exposure Prophylaxis
14%
Pharmacology, Toxicology and Pharmaceutical Science
Monoclonal Antibody
100%
SARS Coronavirus
100%
Coronavirinae
100%
Diseases
100%
Adverse Event
14%
Tolerability
14%